<b>Does adjuvant Metformin reduce Olanzapine-induced metabolic adverse effects in patients diagnosed with Schizophrenia</b>
Butt, Aquib;sadiq, soban
Description
This systematic review assesses the evidence for the effectiveness of utilising adjuvant metformin to reduce olanzapine-induced metabolic adverse effects in patients with schizophrenia
Citations (0)
No citations found
It looks like this dataset has no citations.
Mentions (0)
No mentions found
It looks like this dataset has not been mentioned in any sources.
Metrics Over Time
Publication Details
DOI
Publisher
figshare
Subfield
Psychiatry and Mental health
Field
Medicine
Domain
Health Sciences
Confidence Score
95%
Source
Open Alex
Keywords
Cardiology (incl. cardiovascular diseases)